These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 10541269)

  • 1. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro.
    Dean C; Kanellos J; Pham H; Gomes M; Oates A; Grover P; Ryall R
    Clin Sci (Lond); 2000 Apr; 98(4):471-80. PubMed ID: 10731483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine.
    Ebisuno S; Nishihata M; Inagaki T; Umehara M; Kohjimoto Y
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S436-40. PubMed ID: 10541279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
    Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
    Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of structural domains in inter-alpha-trypsin involved in calcium oxalate crystallization.
    Kobayashi H; Shibata K; Fujie M; Sugino D; Terao T
    Kidney Int; 1998 Jun; 53(6):1727-35. PubMed ID: 9607205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
    Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
    Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
    Moriyama MT; Glenton PA; Khan SR
    J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
    Thongboonkerd V; Semangoen T; Chutipongtanate S
    Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of bikunin and its fragments in the urine of patients with renal stones.
    Suzuki M; Kobayashi H; Kageyama S; Shibata K; Fujie M; Terao T
    J Urol; 2001 Jul; 166(1):268-74. PubMed ID: 11435884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
    Marengo SR; Resnick MI; Yang L; Chung JY
    J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis.
    Iida S; Peck AB; Johnson-Tardieu J; Moriyama M; Glenton PA; Byer KJ; Khan SR
    J Am Soc Nephrol; 1999 May; 10(5):986-96. PubMed ID: 10232684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.